Taiwan Biomaterial Co., Ltd. (TPEX:6649)

Taiwan Biomaterial Revenue

Taiwan Biomaterial had revenue of 36.94M TWD in the quarter ending June 30, 2026, with 9.34% growth. This brings the company's revenue in the last twelve months to 182.32M, up 15.40% year-over-year. In the year 2025, Taiwan Biomaterial had annual revenue of 220.40M with 128.22% growth.

• Revenue (ttm): 182.32M
• Revenue Growth: +15.40%
• P/S Ratio: 8.14
• Revenue / Employee: n/a
• Employees: 46
• Market Cap: 1.48B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	220.40M	123.83M	128.22%
Dec 31, 2024	96.57M	23.74M	32.59%
Dec 31, 2023	72.84M	-54.47M	-42.79%
Dec 31, 2022	127.31M	85.63M	205.48%
Dec 31, 2021	41.67M	23.60M	130.56%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error